{
    "title": "Regeneron plans early summer trials for new antibodies against coronavirus",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8121193/Regeneron-plans-coronavirus-trials-early-summer-newly-identified-antibodies.html",
    "date": "2020-03-17",
    "keywords": [
        "development",
        "vaccine",
        "cocktail",
        "regeneron",
        "drug",
        "antibody",
        "joseph",
        "coronavirus",
        "summer",
        "company",
        "manufacturing",
        "virus",
        "analyst",
        "inc",
        "drugmaker",
        "johnson",
        "sanofi",
        "developer",
        "march",
        "tuesday",
        "treatment",
        "scale",
        "month",
        "end",
        "dozen",
        "history",
        "ebola",
        "effect",
        "value",
        "stock",
        "pfizer",
        "biontech",
        "se",
        "remdesivir",
        "government",
        "agency",
        "moderna",
        "patient",
        "monday",
        "biopharma",
        "industry",
        "valuation",
        "innovation",
        "capability",
        "svb",
        "geoffrey",
        "spokeswoman",
        "alexandra",
        "bowie",
        "lot",
        "line",
        "yet",
        "combination",
        "part",
        "partnership",
        "department",
        "health",
        "research",
        "defense",
        "authority",
        "increase",
        "capacity",
        "addition",
        "kevzara",
        "partner",
        "companys",
        "afternoon",
        "trading",
        "reporting",
        "sibi",
        "bengaluru",
        "editing",
        "shinjini",
        "ganguli",
        "sherry"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}